One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
  • [email protected]
  • +1 718 874 1545 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
Home ➤ Pharmaceutical and Healthcare ➤ Hormonal Contraceptives Market
Hormonal Contraceptives Market
Hormonal Contraceptives Market
Published date: July 2024 • Formats:
Request Sample Schedule a Call
  • Home ➤ Pharmaceutical and Healthcare ➤ Hormonal Contraceptives Market

Global Hormonal Contraceptives Market By Product Type (Emergency Contraceptive Pills, Oral Contraceptive Pills, Injectable Birth Control), By Hormones Type (Combined Hormonal Contraceptive, and Progestin - Only Contraceptive), By User's Age Type (15-24 Years, 25-34 Years, 35-44 Years), By End User Type (Hospitals, Households, Gynecology Centers), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast; 2023-2032

  • Published date: July 2024
  • Report ID: 95696
  • Number of Pages: 284
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Free Sample
  • Quick Navigation

    • Report Overview
    • Key Takeaways
    • By Product Type Analysis
    • By Hormones Type Analysis
    • By The Age Of The User Analysis
    • By End User Type Analysis
    • Key Market Segments
    • Drivers
    • Restraints
    • Opportunity
    • Regional Analysis
    • Key Players Analysis
    • Market Key Players
    • Recent Market Developments
    • Report Scope

    Report Overview

    The Global Hormonal Contraceptives Market size is expected to be worth around USD 24.6 Billion by 2032 from USD 17.3 Billion in 2023, growing at a CAGR of 4.1% during the forecast period from 2023 to 2032.

    Hormonal contraceptives include progesterone and estrogen. It helps to stop pregnancy by stopping egg release from the ovaries, making the lining of the uterus very thin, or thickening the mucus in the cervix to keep sperm away from the egg.

    There are four methods of hormonal contraceptives: the mini pill, the mill, the vaginal ring, and the contraceptive patch with that long-time reversible contraception methods. When hormonal contraceptives are used, they prevent more than 99% of unintended pregnancies. Uterine, ovarian, and colon cancer risks are precluded due to hormonal contraceptives.

    global-hormonal-contraceptives-market

    Key Takeaways

    • The Hormonal Contraceptives Market is expected to reach USD 24.6 billion by 2032.
    • It’s estimated to grow at a CAGR of 4.1% from 2023 to 2032.
    • Hormonal contraceptives help prevent pregnancy by stopping egg release, thinning uterine lining, or thickening cervical mucus.
    • Oral contraceptive pills were the most popular in 2022.
    • Combined hormonal contraceptives dominated the hormone type in 2022.
    • Users aged 15 to 24 formed the majority.
    • Household usage had the largest market share.
    • North America led the market with a 37.5% share in 2022.
    • Hormonal contraceptives are highly effective, preventing over 99% of unplanned pregnancies.
    • Factors driving market growth include increased awareness, government initiatives, and accessibility.
    • Major players invest in research and development and new product commercialization.
    • Oral contraceptives containing estrogen and progesterone are widely used.
    • They are expected to continue dominating due to their accessibility and convenience.
    • The use of oral contraceptives is increasing worldwide.
    • Market growth is fueled by family planning focus, health awareness, and improved contraceptive techniques.
    • Europe’s market is expanding due to product releases, government initiatives, and awareness.
    • Major market players include Abbvie, Bayer, Pfizer, and others.

    By Product Type Analysis

    The Oral Contraceptive Pills Segment Dominated the Largest Market Share in Other Product Types, Owing to its 99% Of Success Rate in Preventing Pregnancy.

    Based on product type, the global hormonal contraceptive Market is segmented into oral contraceptive pills, emergency contraceptive pills, injectable birth control, vaginal rings, intrauterine devices (IUD), transdermal skin patches, and others. Among these products, oral contraceptive pills dominate the largest market share.

    Oral contraceptives will also dominate in the forecast period due to the 99% of success rate in preventing pregnancy. The acceptance of hormonal contraceptives like vaginal rings has a fast market growth rate in the forecast period with lesser side effects and is simple to use.

    Injectable contraceptives have harmful effects such as weight gain, bloating, and depression. The failure rate for female injectables is nearly 6%.

    By Hormones Type Analysis

    The Combined Hormonal Contraceptives Segment Dominated the Largest Market Share In Hormones Type Owing To its Increased Awareness

    The global hormonal contraceptive Market is segmented based on hormone type into progestin-only and combined hormonal contraceptives. Combined hormonal contraceptives dependent on hormones increase these hormones’ overall annual growth rate.

    As people are with increased awareness, government initiatives and programs can help grow overall sales of the hormonal contraceptive Market. Hormonal contraception is used as an endocrine system to prevent unplanned pregnancy.

    By The Age Of The User Analysis

    The 15-24 Years Age Segment Dominated the Largest Market Share In Age Of The User Type Owing To its Increased Awareness Of Hormonal Contraceptives

    Based on age type, the global hormonal contraceptive Market is segmented into 15-24 years, 25-34 years, 35-44 years, and Above 44 Years. Among these users, 15 to 24 aged individuals dominate this sector and will stay dominant in the forecast period.

    The 15 to 24 segment grows due to increased awareness of hormonal contraceptives, problems of unplanned, premarital, and unwanted pregnancy, which leads to abortion, known emergency contraceptive pills, and issues of adolescent-age sexual activity.

    global hormonal contraceptives market by age

    By End User Type Analysis

    Household Segment Dominated the Largest Market Share In End User Type Owing To its Ease of Access

    Based on end-user type, the global hormonal contraceptive market is segmented into hospitals, households, gynecology centers, ambulatory surgical centers, clinics, and others. Among these end-users, the hormonal contraceptive market depends on cost, obtainability, a combination of oral pills, and increased success. The household segment presently will dominate and also in the forecast period.

    As the growth of this segment increases, due to ease of access to contraceptives leads to increases in sexual health. Also, the use of contraceptives helped to improve the health of maternal and infants.

    Key Market Segments

    By Product Type

    • Emergency Contraceptive Pills
    • Oral Contraceptive Pills
    • Vaginal Rings
    • Injectable Birth Control
    • Intrauterine Device (IUD)
    • Transdermal Skin Patches
    • Others

    By Hormones Type

    • Combined Hormonal Contraceptive
    • Progestin-Only Contraceptive

    By User’s Age Type

    • 15-24 Year
    • 25-34 Years
    • 35-44 Years
    • Above 44 Years

    By End User Type

    • Gynecology Centers
    • Household
    • Ambulatory Surgical Centers
    • Hospitals
    • Clinics
    • Others

    Drivers

    Progesterone Injectables Such as Hormonal Contraceptives are Used to Boost Market

    Prominent companies are trying with known celebrities to make people aware of hormonal contraceptives to help avoid unintended pregnancies. The “Women Who Know” campaign is done by celebrity Ashley Tisdale who collaborated with Allergen Plc. This campaign taught women about contraceptive methods such as the hormonal pill Loestrin Fe.

    Restraints

    Some Side Effects such as Headaches, Vaginal Infections, Decrease In Sexual Desire, Mood Swings

    Hormonal contraceptive disadvantages are nausea, sore breasts, headaches, and vaginal yeast infections. There is a slight chance of forming blood clots called thrombosis. The use of hormonal contraceptives may develop mood swings and may decrease the sexual desire of women.

    The more extended intake of oral contraceptives, the greater the risk of cervical-related cancer. If used for 5 years, oral contraceptives increase risk by up to 10%, and if consumed for further 5-9 years, there is an increase in the risk by up to 60%, whereas, after 10 years, it doubles the risk of using contraceptives.

    Opportunity

    Penetration of Untapped Market Of Developing Countries

    Major players in the market are growing due to penetrating the untapped market in developed countries. Day by day, awareness of contraceptive pills is increasing, creating a new untapped market as people try to increase pregnancy age to boost careers or find life’s stability.

    After the Start of The Supply Chain And Production In 2020 Substantial Increase In Sales

    After 2020, some countries stopped the curb on the distribution of family planning services of hormonal contraceptives; after that industry tried to stabilize slowly, normalizing manufacturing and supply chains.

    Regional Analysis

    North America Dominated Hormonal Contraceptive Market Share Owing to Its Availability Of The Most Developed Pharmaceutical Sectors

    North America has a revenue share of 37.5% of the global market. North America has the highest hormonal contraceptive market because of infrastructure, more awareness among people, and the massive pharmaceutical industry. North America has the most major growth of birth control methods because of the availability of the most developed pharmaceutical sectors.

    Asia Pacific has countries such as India and Japan with developed pharmaceutical sectors; hence, they are the second most influential region in the hormonal contraceptive market. As high demand increases in the Asia Pacific sector in the forecast period, it gives a high CAGR to meet increased women’s needs to change their productive age.

    An increasing number of product launches and government initiatives and improved people’s awareness have helped to increase Europe’s regional market. Southeast Asia is one of the best-developing areas with a very high CAGR.

    global hormonal contraceptives market regional analysis

    Key Regions

    • North America
      • The US
      • Canada
      • Mexico
    • Western Europe
      • Germany
      • France
      • The UK
      • Spain
      • Italy
      • Portugal
      • Ireland
      • Austria
      • Switzerland
      • Benelux
      • Nordic
      • Rest of Western Europe
    • Eastern Europe
      • Russia
      • Poland
      • The Czech Republic
      • Greece
      • Rest of Eastern Europe
    • APAC
      • China
      • Japan
      • South Korea
      • India
      • Australia & New Zealand
      • Indonesia
      • Malaysia
      • Philippines
      • Singapore
      • Thailand
      • Vietnam
      • Rest of APAC
    • Latin America
      • Brazil
      • Colombia
      • Chile
      • Argentina
      • Costa Rica
      • Rest of Latin America
    • Middle East & Africa
      • Algeria
      • Egypt
      • Israel
      • Kuwait
      • Nigeria
      • Saudi Arabia
      • South Africa
      • Turkey
      • United Arab Emirates
      • Rest of MEA

    Key Players Analysis

    There are a lot of key players in the hormonal contraceptive market due to the presence of many generic drugs. To increase the share of each player, product strategies like commercialization, boost in area reach, approval of product, and increase in the application scope are used. In Feb 2020, companies such as Agile Therapeutics, Inc. for Twirla (patch with Ethinylestradiol and levonorgestrel) got US FDA approval.

    Market Key Players

    • Abbvie Inc.
    • Afaxys, Inc.
    • Bayer AG
    • Pfizer, Inc
    • Johnson & Johnson
    • Janssen Pharmaceuticals Inc.
    • Lupin Pharmaceuticals Inc.
    • Pregna International Ltd.
    • The Female Health Company
    • Teva Pharmaceutical Industries Limited
    • Mylan N.V.
    • Ansell LTD
    • Merck & Co. Inc.
    • Church & Dwight, Co, Inc.
    • Mayer Laboratories
    • Novartis ag
    • Agile Therapeutics
    • Other Key Players

    Recent Market Developments

    • Abbvie Inc. (March 2024): Abbvie Inc. acquired Repros Therapeutics Inc., aiming to strengthen its portfolio in women’s health, particularly in hormonal contraceptives. This acquisition is expected to enhance Abbvie’s offerings and expand its market reach.
    • Afaxys, Inc.(April 2024): Afaxys, Inc. launched a new low-dose oral contraceptive, Afaxys One, in April 2024. This product aims to provide effective birth control with fewer side effects, catering to women seeking safer and more convenient contraceptive options.
    • Bayer AG (February 2024): Bayer AG acquired KaNDy Therapeutics, aiming to expand its women’s healthcare portfolio. This acquisition will enhance Bayer’s research capabilities and product offerings in the hormonal contraceptives market, focusing on innovative solutions.
    • Pfizer, Inc.(January 2024): Pfizer, Inc. introduced a new contraceptive implant, PrevCon, in January 2024. PrevCon offers long-term birth control with a single implant, providing a convenient and effective option for women seeking extended protection.
    • Johnson & Johnson (March 2024): Johnson & Johnson announced a merger with Agile Therapeutics in March 2024. This merger aims to combine Agile’s innovative contraceptive patch technology with Johnson & Johnson’s extensive market presence, enhancing their hormonal contraceptive product lineup.

    Report Scope

    Report Features Description
    Market Value (2023) USD 17.3 Billion
    Forecast Revenue (2032) USD 24.6 Billion
    CAGR (2023-2032) 4.1%
    Base Year for Estimation 2022
    Historic Period 2016-2021
    Forecast Period 2023-2032
    Report Coverage Revenue Forecast, Market Dynamics, Competitive Landscape, Recent Developments
    Segments Covered By Product Type(Emergency Contraceptive Pills, Oral Contraceptive Pills, Injectable Birth Control, Vaginal Rings, Intrauterine Device (IUD), and Transdermal Patches), By Hormones Type (Combined Hormonal Contraceptive and Progestin-Only Contraceptive), By User’s Age Type(15-24 years, 25-34 years, 35-44 years, and Above 44 Years), By End User Type (Hospitals, Household, Gynecology Centers, Ambulatory Surgical Centers, and Clinics)
    Regional Analysis North America – US, Canada, Mexico; Western Europe – Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic; Eastern Europe – Russia, Poland, The Czech Republic, Greece; APAC – China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam; Latin America – Brazil, Colombia, Chile, Argentina, Costa Rica; Middle East & Africa – Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates
    Competitive Landscape Abbvie, Inc.; Afaxys, Inc.; Teva Pharmaceuticals Industries Ltd; Merck & Co. Inc.; The Female Health Company; Bayer AG, Pfizer, Inc.; Mylan N.V.; Johnson & Johnson; Ansell LTD; Mayer Laboratories; Church & Dwight, Co, Inc., and others
    Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements.
    Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF)

    Frequently Asked Questions (FAQ)

    What are hormonal contraceptives?

    Hormonal contraceptives are medications used to prevent pregnancy by regulating hormones. They include pills, patches, injections, implants, and intrauterine devices (IUDs) that release hormones such as estrogen and progestin.

    How big is the Hormonal Contraceptives Market?

    The global Hormonal Contraceptives Market size was estimated at USD 17.3 Billion in 2023 and is expected to reach USD 24.6 Billion in 2033.

    What is the Hormonal Contraceptives Market growth?

    The global Hormonal Contraceptives Market is expected to grow at a compound annual growth rate of 4.1%. From 2024 To 2033

    Who are the key companies/players in the Hormonal Contraceptives Market?

    Some of the key players in the Hormonal Contraceptives Markets are Abbvie, Inc.; Afaxys, Inc.; Teva Pharmaceuticals Industries Ltd; Merck & Co. Inc.; The Female Health Company; Bayer AG, Pfizer, Inc.; Mylan N.V.; Johnson & Johnson; Ansell LTD; Mayer Laboratories; Church & Dwight, Co, Inc., and others

    How do hormonal contraceptives work?

    Hormonal contraceptives prevent ovulation, thicken cervical mucus to block sperm, and thin the uterine lining to prevent implantation. These mechanisms collectively reduce the likelihood of pregnancy.

    What are the benefits of using hormonal contraceptives?

    Benefits include effective pregnancy prevention, regulation of menstrual cycles, reduced menstrual cramps, and decreased risk of ovarian cysts and certain cancers. They can also manage symptoms of conditions like polycystic ovary syndrome (PCOS).

    What factors are driving the growth of the hormonal contraceptives market?

    Factors driving growth include increased awareness of family planning, advancements in contraceptive technologies, a growing focus on women's health, and supportive government policies promoting contraceptive use.

    What challenges does the hormonal contraceptives market face?

    Challenges include potential side effects, cultural and religious opposition, limited access in some regions, and the need for continuous research and development to improve efficacy and reduce adverse effects.

    Hormonal Contraceptives Market
    Hormonal Contraceptives Market
    Published date: July 2024
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
    • AbbVie Inc. Company Profile
    • Afaxys, Inc.
    • Bayer AG Company Profile
    • Pfizer, Inc
    • Johnson & Johnson
    • Janssen Pharmaceuticals Inc.
    • Lupin Pharmaceuticals Inc.
    • Pregna International Ltd.
    • The Female Health Company
    • Teva Pharmaceutical Industries Limited
    • Mylan N.V.
    • Ansell Ltd. Company Profile
    • Merck & Co. Inc.
    • Church & Dwight, Co, Inc.
    • Mayer Laboratories
    • Novartis AG Company Profile
    • Agile Therapeutics
    • Other Key Players
  • settingsSettings

Related Reports

  • Bioelectric Medicine Market
  • Multiple Sclerosis Drugs Market
  • Excipients Market
  • Erectile Dysfunction Drugs Market
  • Schizophrenia Drugs Market
  • Pharmaceutical Cartridges Market
  • Viscosupplementation Market
  • Dry Eye Syndrome Market
  • Foley Catheter Market
  • Peptic Ulcer Drugs Market

Our Clients

  • Our Clients
Inquiry Before Buying

Hormonal Contraceptives Market
  • 95696
  • July 2024
    • ★★★★★
      ★★★★★
    • (75)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 874 1545 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
Secured Payment Options
Secured Payment Options

© 2025 Market.Us. All Rights Reserved.